BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on previous and upcoming congresses
Upcoming Congress Events
2025 Hereditary Angioedema Association (HAEA) US Summit Congress
BioCryst will attend the 2025 Hereditary Angioedema Association (HAEA) US Summit Congress from July 10-13, 2025.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 101 Materials
-
Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
EAACI | 2025 | Hereditary Angioedema (HAE) -
Assessment of the Effectiveness and Tolerability of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Findings from the Berolife Study
EAACI | 2025 | Hereditary Angioedema (HAE) -
Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results From a Focus Group
EAACI | 2025 | Hereditary Angioedema (HAE) -
Impact of Berotralstat on Quality of Life in Patients with Hereditary Angioedema
EAACI | 2025 | Hereditary Angioedema (HAE) -
Berotralstat for the Prevention of Hereditary Angioedema Attacks: Results from the Italian Expanded Access Programme
C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE)
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
Ready to connect or have a question?
Have questions about any of our medicines that are currently approved or in development, or would you like to request to be connected with an MSL?
Have questions about our company?